Symbols / RKDA $1.09 -2.68% Arcadia Biosciences, Inc.

Consumer Defensive • Packaged Foods • United States • NCM
RKDA Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Fundamentals
Scroll to Statements
Market Cap 2.24M Enterprise Value -2.32M Income -2.34M Sales 4.86M Book/sh 3.02 Cash/sh 2.22
Dividend Yield — Payout 0.00% Employees 8 IPO — P/E — Forward P/E -0.85
PEG — P/S 0.46 P/B 0.36 P/C — EV/EBITDA 0.45 EV/Sales -0.48
Quick Ratio 2.42 Current Ratio 3.09 Debt/Eq — LT Debt/Eq — EPS (ttm) -1.71 EPS next Y -1.28
EPS Growth — Revenue Growth -25.90% Earnings 2026-03-19 ROA -32.71% ROE -45.14% ROIC —
Gross Margin 36.04% Oper. Margin -152.61% Profit Margin -48.15% Shs Outstand 2.06M Shs Float 2.05M Short Float 0.05%
Short Ratio 0.02 Short Interest — 52W High 6.71 52W Low 0.89 Beta 0.72 Avg Volume 34.67K
Volume 15.52K Target Price — Recom None Prev Close $1.12 Price $1.09 Change -2.68%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.09
Latest analyst target
3. DCF / Fair value
$6.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.09
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-08-21 reit HC Wainwright & Co. Buy → Buy $6
2024-05-23 main HC Wainwright & Co. Buy → Buy $6
2024-04-05 reit HC Wainwright & Co. Buy → Buy $10
2023-08-28 main HC Wainwright & Co. Buy → Buy $10
2023-07-24 reit HC Wainwright & Co. Buy → Buy $15
2023-06-05 main HC Wainwright & Co. Buy → Buy $15
2023-04-14 main HC Wainwright & Co. — → Buy $18
News
RSS: Latest RKDA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-02-03 SCHAEFER THOMAS J. Chief Executive Officer — 700 $5.00 $3,500
2024-08-01 KAWAKAMI MARK Chief Financial Officer — 700 $2.93 $2,051
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
4.86
-3.71%
5.04
+13.27%
4.45
-39.96%
7.42
Operating Revenue
4.86
-3.71%
5.04
+13.27%
4.45
-39.96%
7.42
Cost Of Revenue
3.10
+4.56%
2.96
+36.29%
2.17
-64.37%
6.10
Reconciled Cost Of Revenue
3.10
+4.56%
2.96
+36.29%
2.17
-64.37%
6.10
Gross Profit
1.76
-15.47%
2.08
-8.68%
2.28
+73.12%
1.32
Operating Expense
11.76
+21.26%
9.69
+16.82%
8.30
-49.85%
16.55
Research And Development
0.01
-83.02%
0.05
-17.19%
0.06
-95.76%
1.51
Selling General And Administration
7.00
-27.38%
9.64
+17.09%
8.23
-45.24%
15.04
Total Expenses
14.85
+17.35%
12.66
+20.87%
10.47
-53.76%
22.65
Operating Income
-9.99
-31.31%
-7.61
-26.49%
-6.02
+60.48%
-15.23
Total Operating Income As Reported
-2.50
+31.47%
-3.65
+40.22%
-6.10
+56.44%
-14.01
EBITDA
-9.96
-32.86%
-7.50
-30.85%
-5.73
+61.14%
-14.75
Normalized EBITDA
-15.10
-51.14%
-9.99
-63.35%
-6.12
+68.12%
-19.18
Reconciled Depreciation
0.03
-71.68%
0.11
-60.63%
0.29
-40.08%
0.48
EBIT
-9.99
-31.31%
-7.61
-26.49%
-6.02
+60.48%
-15.23
Total Unusual Items
5.13
+106.18%
2.49
+548.44%
0.38
-91.33%
4.43
Total Unusual Items Excluding Goodwill
5.13
+106.18%
2.49
+548.44%
0.38
-91.33%
4.43
Special Income Charges
2.75
-30.63%
3.96
+4819.05%
-0.08
-106.88%
1.22
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
0.00
-100.00%
0.04
-68.14%
0.11
-62.46%
0.30
Restructuring And Mergern Acquisition
-2.00
0.00
0.00
+100.00%
-0.07
Net Income
-2.34
+66.77%
-7.04
+49.66%
-13.98
+9.07%
-15.38
Pretax Income
-2.33
+45.90%
-4.31
+19.02%
-5.32
+50.80%
-10.81
Net Non Operating Interest Income Expense
0.22
-71.74%
0.78
+12.52%
0.69
+140.48%
0.29
Interest Expense Non Operating
—
—
—
—
Net Interest Income
0.22
-71.74%
0.78
+12.52%
0.69
+140.48%
0.29
Interest Expense
—
—
—
—
Interest Income Non Operating
0.22
-71.74%
0.78
+12.52%
0.69
+140.48%
0.29
Interest Income
0.22
-71.74%
0.78
+12.52%
0.69
+140.48%
0.29
Other Income Expense
7.44
+195.24%
2.52
+125950.00%
0.00
-99.95%
4.12
Other Non Operating Income Expenses
2.31
+7348.39%
0.03
+108.12%
-0.38
-25.25%
-0.30
Gain On Sale Of Security
2.38
+261.74%
-1.47
-414.96%
0.47
-85.42%
3.21
Gain On Sale Of Business
—
—
0.00
-100.00%
1.14
Tax Provision
0.01
+0.00%
0.01
+0.00%
0.01
-42.86%
0.01
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+20900.00%
0.00
Tax Effect Of Unusual Items
1.08
+106.18%
0.52
+548.44%
0.08
+1720.32%
0.00
Net Income Including Noncontrolling Interests
-2.34
+66.77%
-7.04
+49.68%
-13.99
+10.42%
-15.61
Net Income From Continuing Operation Net Minority Interest
-2.34
+45.82%
-4.32
+18.91%
-5.32
+49.74%
-10.59
Net Income From Continuing And Discontinued Operation
-2.34
+66.77%
-7.04
+49.66%
-13.98
+9.07%
-15.38
Net Income Continuous Operations
-2.34
+45.82%
-4.32
+18.99%
-5.33
+50.79%
-10.83
Net Income Discontinuous Operations
0.00
+100.00%
-2.72
+68.57%
-8.66
-80.96%
-4.78
Minority Interests
—
0.00
-100.00%
0.01
-97.88%
0.24
Normalized Income
-6.39
-1.76%
-6.28
-11.67%
-5.63
+62.53%
-15.02
Net Income Common Stockholders
-2.34
+66.77%
-7.04
+49.66%
-13.98
+9.07%
-15.38
Diluted EPS
-1.71
+66.92%
-5.17
+54.21%
-11.29
+55.98%
-25.65
Basic EPS
-1.71
+66.92%
-5.17
+54.21%
-11.29
+55.98%
-25.65
Basic Average Shares
1.37
+0.35%
1.36
+10.22%
1.24
+106.37%
0.60
Diluted Average Shares
1.37
+0.35%
1.36
+10.22%
1.24
+106.37%
0.60
Diluted NI Availto Com Stockholders
-2.34
+66.77%
-7.04
+49.66%
-13.98
+9.07%
-15.38
Gain On Sale Of PPE
0.75
-81.25%
4.00
+13693.10%
0.03
-90.76%
0.31
Provision For Doubtful Accounts
4.75
0.00
—
—
Total Other Finance Cost
—
—
—
-0.29
Line Item Trend 2023-12-31
Total Assets
19.70
Current Assets
14.97
Cash Cash Equivalents And Short Term Investments
11.64
Cash And Cash Equivalents
6.52
Other Short Term Investments
5.12
Receivables
0.51
Accounts Receivable
0.51
Gross Accounts Receivable
0.51
Allowance For Doubtful Accounts Receivable
0.00
Inventory
0.84
Raw Materials
—
Finished Goods
—
Prepaid Assets
—
Assets Held For Sale Current
1.18
Other Current Assets
0.81
Total Non Current Assets
4.73
Net PPE
0.86
Gross PPE
2.80
Accumulated Depreciation
-1.94
Properties
0.00
Machinery Furniture Equipment
0.42
Other Properties
0.79
Leases
1.59
Goodwill And Other Intangible Assets
0.04
Goodwill
—
Other Intangible Assets
0.04
Other Non Current Assets
3.83
Total Liabilities Net Minority Interest
7.00
Current Liabilities
3.59
Payables And Accrued Expenses
1.97
Payables
0.54
Accounts Payable
0.48
Other Payable
0.04
Current Accrued Expenses
1.43
Current Debt And Capital Lease Obligation
0.85
Current Capital Lease Obligation
0.85
Current Deferred Liabilities
—
Current Deferred Revenue
—
Other Current Liabilities
0.77
Total Non Current Liabilities Net Minority Interest
3.41
Long Term Debt And Capital Lease Obligation
0.15
Long Term Capital Lease Obligation
0.15
Other Non Current Liabilities
2.00
Stockholders Equity
12.84
Common Stock Equity
12.84
Capital Stock
0.07
Common Stock
0.07
Share Issued
1.29
Ordinary Shares Number
1.29
Treasury Shares Number
0.00
Additional Paid In Capital
284.51
Retained Earnings
-271.84
Gains Losses Not Affecting Retained Earnings
0.10
Minority Interest
-0.14
Other Equity Adjustments
0.10
Total Equity Gross Minority Interest
12.70
Total Capitalization
12.84
Working Capital
11.38
Invested Capital
12.84
Total Debt
1.01
Capital Lease Obligations
1.01
Net Tangible Assets
12.80
Tangible Book Value
12.80
Derivative Product Liabilities
1.26
Dueto Related Parties Current
0.06
Non Current Note Receivables
0.00
Notes Receivable
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.74
+50.77%
-9.63
+37.05%
-15.29
-9.42%
-13.98
Cash Flow From Continuing Operating Activities
-4.74
+50.77%
-9.63
+37.05%
-15.29
-9.42%
-13.98
Net Income From Continuing Operations
-2.34
+66.77%
-7.04
+49.68%
-13.99
+10.42%
-15.61
Depreciation Amortization Depletion
0.03
-71.68%
0.11
-60.63%
0.29
-40.08%
0.48
Depreciation
0.03
-71.68%
0.11
-60.63%
0.29
-34.62%
0.44
Amortization Cash Flow
—
—
0.00
-100.00%
0.04
Depreciation And Amortization
0.03
-71.68%
0.11
-60.63%
0.29
-40.08%
0.48
Amortization Of Intangibles
—
—
0.00
-100.00%
0.04
Other Non Cash Items
0.37
+204.79%
-0.35
-105.51%
6.44
+3185.20%
0.20
Stock Based Compensation
0.23
-54.30%
0.51
-28.59%
0.72
-35.17%
1.11
Asset Impairment Charge
0.00
-100.00%
0.33
-43.15%
0.58
-83.35%
3.46
Deferred Tax
—
—
—
—
Deferred Income Tax
—
—
—
—
Operating Gains Losses
-3.13
-20.96%
-2.59
+60.65%
-6.58
-41.26%
-4.66
Gain Loss On Investment Securities
-2.38
-261.74%
1.47
+122.52%
-6.54
-103.93%
-3.21
Unrealized Gain Loss On Investment Securities
—
—
—
—
Gain Loss On Sale Of PPE
-0.75
+81.55%
-4.07
-10062.50%
-0.04
+87.26%
-0.31
Change In Working Capital
0.10
+116.11%
-0.60
+78.28%
-2.74
-361.33%
1.05
Change In Receivables
0.17
+121.65%
-0.76
-514.13%
0.18
-68.92%
0.59
Changes In Account Receivables
—
—
0.18
-68.92%
0.59
Change In Inventory
-0.31
-156.00%
0.55
+122.74%
-2.42
-316.37%
1.12
Change In Prepaid Assets
0.78
+725.00%
-0.12
-12500.00%
0.00
-98.90%
0.09
Change In Payables And Accrued Expense
-0.43
-29.22%
-0.33
+35.16%
-0.51
+33.76%
-0.77
Change In Payable
-0.43
-29.22%
-0.33
+35.16%
-0.51
+33.76%
-0.77
Change In Account Payable
-0.40
-31.68%
-0.30
+41.95%
-0.52
+31.04%
-0.76
Change In Other Working Capital
—
—
—
—
Change In Other Current Assets
-0.05
-169.44%
0.07
+3500.00%
0.00
-87.50%
0.02
Change In Other Current Liabilities
-0.06
0.00
0.00
-100.00%
0.01
Investing Cash Flow
0.75
-89.78%
7.34
+269.01%
-4.34
-406.56%
1.42
Cash Flow From Continuing Investing Activities
0.75
-89.78%
7.34
+269.01%
-4.34
-406.56%
1.42
Net PPE Purchase And Sale
0.00
-100.00%
0.32
+189.09%
0.11
-87.03%
0.85
Purchase Of PPE
0.00
+100.00%
-0.02
-220.00%
-0.01
+93.06%
-0.07
Sale Of PPE
0.00
-100.00%
0.33
+190.43%
0.12
-87.50%
0.92
Capital Expenditure
—
-0.02
-220.00%
-0.01
+93.06%
-0.07
Net Investment Purchase And Sale
0.00
-100.00%
5.02
+200.02%
-5.02
0.00
Purchase Of Investment
—
0.00
+100.00%
-7.53
0.00
Sale Of Investment
0.00
-100.00%
5.02
+100.80%
2.50
0.00
Net Business Purchase And Sale
0.00
+100.00%
-2.00
-451.49%
0.57
+0.00%
0.57
Purchase Of Business
0.00
+100.00%
-2.00
0.00
0.00
Gain Loss On Sale Of Business
—
—
0.00
+100.00%
-1.14
Net Intangibles Purchase And Sale
0.75
-81.25%
4.00
0.00
—
Financing Cash Flow
0.01
-33.33%
0.01
-99.84%
5.51
+21.97%
4.52
Cash Flow From Continuing Financing Activities
0.01
-33.33%
0.01
-99.84%
5.51
+21.97%
4.52
Net Issuance Payments Of Debt
—
—
—
0.00
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
—
0.00
-100.00%
6.00
+19.94%
5.00
Proceeds From Stock Option Exercised
0.01
-33.33%
0.01
-25.00%
0.01
+71.43%
0.01
Net Other Financing Charges
—
—
-0.50
-1.84%
-0.49
Changes In Cash
-3.98
-75.00%
-2.28
+83.89%
-14.13
-75.67%
-8.04
Effect Of Exchange Rate Changes
—
—
—
0.00
Beginning Cash Position
4.24
-34.92%
6.52
-68.43%
20.64
-28.03%
28.68
End Cash Position
0.26
-93.89%
4.24
-34.92%
6.52
-68.43%
20.64
Free Cash Flow
-4.74
+50.86%
-9.64
+36.97%
-15.30
-8.90%
-14.05
Interest Paid Supplemental Data
—
—
0.00
-100.00%
0.00
Income Tax Paid Supplemental Data
—
—
—
0.00
Amortization Of Securities
—
—
—
—
Common Stock Issuance
—
0.00
-100.00%
6.00
+19.94%
5.00
Issuance Of Capital Stock
—
0.00
-100.00%
6.00
+19.94%
5.00
Sale Of Business
—
0.00
-100.00%
0.57
+0.00%
0.57
Sale Of Intangibles
0.75
-81.25%
4.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category